News
House tax bill includes PBM reforms, spread pricing restrictions & orphan drug negotiation changes, with Rep. Guthrie leading ...
Roche said its $50 billion promise to expand its manufacturing footprint in the US has the potential to be 'reassessed.' ...
Exclusive: Patrick Hsu startup launches, looks beyond CRISPR for gene insertion technology
Stylus Medicine, a startup founded by Patrick Hsu, has raised $85 million to develop a suite of technologies that it believes ...
Vir Biotech's hepatitis B therapy shows 4% cure rate with doublet (tobevibart/elebsiran) and 10% with triplet therapy, below ...
FDA clears Ensoma's trial of in vivo blood stem cell editing therapy for X-linked chronic granulomatous disease, following China's Yoltech earlier this year.
The White House outlined plans to force down prices of drugs sold in the US using the threat of tying costs to rates paid by ...
New data shows Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy in weight loss, with 65% vs 40% of patients achieving ...
President Donald Trump said he’ll take executive action to have the US pay no more than other countries for drugs, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results